The University of Iowa
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us
 
CONTACT: LINDSAY RUNYAN
5141 Westlawn
Iowa City IA 52242
(319) 335-9585; fax (319) 384-4638
e-mail: lindsay-runyan@uiowa.edu
Release: June 17, 2002

Note to Editors: This release originally was distributed April 25, 2002. People are still welcome to participate in the study.

People with OCD invited to participate in UI study

People with obsessive compulsive disorder (OCD) are invited to participate in a University of Iowa Health Care treatment study. The study will examine the effectiveness of a new medication to treat OCD. Some participants will receive a placebo (inactive medication).

Participants must be between the ages of 18 and 65 and cannot be abusing alcohol or drugs. Participants must be able to remain free of any prescription or nonprescription psychotropic drugs for two weeks, give prior consent to participate and sign an informed consent. Women must not be pregnant or planning to get pregnant during the study period. The study will consist of a two- to four- week, single-blind, placebo screening period, 12 weeks of double-blind treatment, followed by one week of placebo washout. The first visit includes a physical examination. The follow-up visits involve assessment of the participant's disorder as well as discussion of the medication and its side effects.

For more information, contact the study's lead investigator, Donald W. Black, M.D., UI professor of psychiatry, at (319) 353-4431.

University of Iowa Health Care describes the partnership between the UI Roy J. and Lucille A. Carver College of Medicine and the UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide. Visit UI Health Care online at www.uihealthcare.com.